Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas.
Jancik S, Drabek J, Berkovcova J, Xu YZ, Stankova M, Klein J, Kolek V, Skarda J, Tichy T, Grygarkova I, Radzioch D, Hajduch M. Jancik S, et al. Among authors: kolek v. J Exp Clin Cancer Res. 2012 Sep 20;31(1):79. doi: 10.1186/1756-9966-31-79. J Exp Clin Cancer Res. 2012. PMID: 22995035 Free PMC article.
Correlation between BRCA1 expression and clinicopathological factors including brain metastases in patients with non-small-cell lung cancer.
Gachechiladze M, Uberall I, Kolek V, Klein J, Krejci V, Stastna J, Radova L, Fridman E, Skarda J. Gachechiladze M, et al. Among authors: kolek v. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Sep;157(3):227-32. doi: 10.5507/bp.2012.099. Epub 2012 Nov 1. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013. PMID: 23128816 Free article.
Long term follow-up of neoadjuvant-adjuvant combination treatment of IIIA stage non-small-cell-lung cancer: results of neoadjuvant carboplatin/vinorelbine and carboplatin/paclitaxel regimens combined with selective adjuvant chemotherapy according to in-vitro chemoresistance test.
Kolek V, Grygarkova I, Hajduch M, Klein J, Cwiertka K, Neoral C, Langova K, Mihal V. Kolek V, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Dec;152(2):259-66. doi: 10.5507/bp.2008.040. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008. PMID: 19219217 Free article. Clinical Trial.
Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer.
Janikova M, Skarda J, Dziechciarkova M, Radova L, Chmelova J, Krejci V, Sedlakova E, Zapletalova J, Langova K, Klein J, Grygarkova I, Kolek V. Janikova M, et al. Among authors: kolek v. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010 Dec;154(4):321-6. doi: 10.5507/bp.2010.048. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010. PMID: 21293543
Lung resection in a neoadjuvant protocol.
Klein J, Král V, Neoral C, Bohanes T, Aujeský R, Kolek V, Grygárková I, Hajdúch M, Tichý T. Klein J, et al. Among authors: kolek v. Med Sci Monit. 2000 Sep-Oct;6(5):937-40. Med Sci Monit. 2000. PMID: 11208434
181 results